Esperion Therapeutics Inc 's ability to collect accounts receivable sequentially worsen to 3.35, indicating more challenging environment then in the fourth quarter 2025, but still, it is a far cry from any concerns. Esperion Therapeutics Inc 's Accounts Receivable average collection period in the Mar 31 2026 quarter, has increased to 109 days, from 101 days, in the Dec 31 2025 quarter.

If we take a look into Healthcare sector 86 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Mar 31 2026 from 529 to 710.

What is Receivable Turnover Ratio?
What is Esperion Therapeutics Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

ESPR Receivables Turnover Ratio	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter	(Mar 31 2025) I. Quarter
Y / Y Receivable Change	62.81 %	74.93 %	75.42 %	78.51 %	48.86 %
Y / Y Revenue Change	23.25 %	143.73 %	69.1 %	11.58 %	-52.81 %
Receivable Turnover Ratio (TTM)	3.35	3.6	3.13	3.18	3.59
ESPR's Total Ranking	# 710	# 529	# 1071	# 1137	# 620
Accounts Receivable average collection period days	109	101	117	115	102
Seq. Receivable Change	-5.59 %	17.83 %	10.43 %	32.54 %	1.44 %
Seq. Revenue Change	-52.45 %	92.93 %	5.98 %	26.76 %	-5.96 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 19
Healthcare Sector	# 87
Overall Market	# 710

Receivable Turnover Ratio Statistics
High	Average	Low
1.07	0.6	0.02
(Dec 31 2025)		(Mar 31 2020)

ESPR Company Profile • Back to ESPR Efficiency Comparisons • Compare ESPR Receivables Turnover Ratio to its Competitors

Financial Statements
Esperion Therapeutics Inc 's Accounts Receivable	$ 132 Millions	Visit ESPR's Balance sheet
Esperion Therapeutics Inc 's Sales TTM	$ 418 Millions	Visit ESPR's Income Statement
Sources of ESPR's Revenues		Visit ESPR's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
ESPR's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
ESPR's Growth Rates	ESPR's Roa	ESPR's Inventory Turnover Ratio	ESPR's Dividend Comparisons
ESPR's Profitability Ratios	ESPR's Roi	ESPR's Asset Turnover Ratio	ESPR's Dividend Growth
ESPR's Valuation Ratios	ESPR's Roe	ESPR's Financial Strength Ratios	ESPR's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Mar 31 2026, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Mar 31 2026	Receivable at quarter ending Mar 31 2026
Scientific Industries Inc	8.65	$ 6.588 Millions	$ 0.761 Millions
Sanara Medtech Inc	8.60	$ 106.873 Millions	$ 12.423 Millions
Protalix Biotherapeutics inc	8.57	$ 76.381 Millions	$ 8.912 Millions
Adapthealth Corp	8.55	$ 3,286.774 Millions	$ 384.194 Millions
Perrigo Company Plc	8.52	$ 4,177.500 Millions	$ 490.200 Millions
Alpha Teknova Inc	8.48	$ 43.582 Millions	$ 5.141 Millions
Ensign Group Inc	8.47	$ 5,273.996 Millions	$ 622.757 Millions
Axogen inc	8.41	$ 238.105 Millions	$ 28.322 Millions
Tenet Healthcare Corp	8.40	$ 21,455.000 Millions	$ 2,555.250 Millions
Pediatrix Medical Group Inc	8.36	$ 1,931.686 Millions	$ 231.145 Millions
Alpha Pro Tech Ltd	8.32	$ 59.661 Millions	$ 7.167 Millions
Guardant Health Inc	8.29	$ 1,080.215 Millions	$ 130.272 Millions
Aspira Women s Health inc	8.26	$ 10.792 Millions	$ 1.307 Millions
Atricure Inc	8.24	$ 549.625 Millions	$ 66.737 Millions
Aquestive Therapeutics Inc	8.16	$ 50.271 Millions	$ 6.158 Millions
Caredx Inc	8.16	$ 412.820 Millions	$ 50.605 Millions
Rockwell Medical inc	8.09	$ 67.550 Millions	$ 8.345 Millions
Concentra Group Holdings Parent Inc	8.08	$ 2,232.220 Millions	$ 276.283 Millions
Becton Dickinson And Company	8.02	$ 21,366.000 Millions	$ 2,662.500 Millions
Vycor Medical Inc	8.01	$ 1.886 Millions	$ 0.235 Millions
Sotera Health Company	8.01	$ 1,188.171 Millions	$ 148.349 Millions
Orthofix Medical Inc	7.99	$ 824.944 Millions	$ 103.310 Millions
Penumbra Inc	7.94	$ 1,454.283 Millions	$ 183.070 Millions
Alphatec Holdings Inc	7.93	$ 786.368 Millions	$ 99.110 Millions
Henry Schein Inc	7.92	$ 13,384.000 Millions	$ 1,689.500 Millions
Sight Sciences Inc	7.91	$ 78.550 Millions	$ 9.925 Millions
Aveanna Healthcare Holdings Inc	7.91	$ 2,521.890 Millions	$ 318.786 Millions
Trisalus Life Sciences Inc	7.91	$ 44.183 Millions	$ 5.586 Millions
Beta Bionics Inc	7.89	$ 110.003 Millions	$ 13.950 Millions
Acadia Pharmaceuticals Inc	7.88	$ 1,095.250 Millions	$ 138.935 Millions

Date modified: 2026-08-30T14:54:54+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.